Epidermal Growth Factor Receptor Inhibitors in Colorectal Cancer: It's Time to Get Back on Target
- 20 March 2005
- journal article
- editorial
- Published by American Society of Clinical Oncology (ASCO) in Journal of Clinical Oncology
- Vol. 23 (9), 1791-1793
- https://doi.org/10.1200/jco.2005.10.951
Abstract
No abstract availableThis publication has 25 references indexed in Scilit:
- Immunohistochemical Detection of EGFR in Paraffin-embedded Tumor TissuesJournal of Histochemistry & Cytochemistry, 2004
- EGFR Mutations in Lung Cancer: Correlation with Clinical Response to Gefitinib TherapyScience, 2004
- Activating Mutations in the Epidermal Growth Factor Receptor Underlying Responsiveness of Non–Small-Cell Lung Cancer to GefitinibNew England Journal of Medicine, 2004
- Phase II Trial of Cetuximab in Patients With Refractory Colorectal Cancer That Expresses the Epidermal Growth Factor ReceptorJournal of Clinical Oncology, 2004
- Phase I Study of the Humanized Antiepidermal Growth Factor Receptor Monoclonal Antibody EMD72000 in Patients With Advanced Solid Tumors That Express the Epidermal Growth Factor ReceptorJournal of Clinical Oncology, 2004
- Kinase Mutations and Imatinib Response in Patients With Metastatic Gastrointestinal Stromal TumorJournal of Clinical Oncology, 2003
- Color multiplex polymerase chain reaction for quantitative analysis of epidermal growth factor receptor genes in colorectal adenocarcinomaJournal of Surgical Oncology, 2003
- Heterodimerization and functional interaction between EGF receptor family members: a new signaling paradigm with implications for breast cancer researchBreast Cancer Research and Treatment, 1995
- Epidermal growth factorBioscience Reports, 1986
- Close similarity of epidermal growth factor receptor and v-erb-B oncogene protein sequencesNature, 1984